Mapping of the epitope recognized by non-specific cytotoxic cells: Determination of the fine specificity using synthetic peptides

Scandinavian Journal of Immunology

Volumn 43, Issue 5, 1996, Pages 556-565

  Evans, D L ^a   Leary III, J H ^a   Weisman, Z ^b   Warren, J ^a   Jaso Friedmann, L ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b KAPLAN HOSPITAL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

SYNTHETIC PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CATFISH; CYTOTOXICITY; EPITOPE MAPPING; FLOW CYTOMETRY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0029967243     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-81.x     Document Type: Article

References (40)

1. Evans DL, Jaso-Friedmann L, Smith EE Jr, St. John A, Koren HS, Harris DT. Identification of a putative antigen receptor on fish nonspecific cytotoxic cells with monoclonal antibodies. J Immunol 1988;141:324-38.
2. Evans DL, Jaso-Friedmann L. Nonspecific cytotoxic cells as effectors of immunity in fish. Ann Rev Fish Dis 1992;2:109-21.
3. Evans DL, Jaso-Friedmann L. NK cells in domestic animals: phenotype, target cell specificity and cytokine regulation. Vet Res Communication 1993;17:429-47.
4. Graves LL, Evans DL, Dawe DL. Antiprotozoan activity of nonspecific cytotoxic cells (NCC) from the channel catfish (Ictalurus punctatus). J Immunol 1985;134:78-85.
5. Graves LL, Evans DL, Dawe DL. Mobilization and activation of nonspecific cytotoxic cells (NCC) in the channel catfish (Ictalurus punctatus) infected with Ichthyophthirius multifiliis. Comp Immunol Microbiol Infect Dis 1985;8:43-51.
6. Ojo-Amaize EA, Vilchek J, Cochrane AH, Nussenqweig RS. Plasmodium berghei sporozoites are mitogenic for murine T cells, induce interferon, and activate natural killer cells. J Immunol 1984;133:1005-9.
7. Solomon JB, Forbes MG, Solomon, G.R. A possible role for natural killer cells in providing protection against Plasmodium berghei in early stages of infection. Immunol Lett 1985;9:349-58.
8. Eugui EM, Allison A. Natural cell-mediated immunity and interferon in malaria and babesia infections. In: Herberman RB, ed. NK Cells and Other Natural Effector Cells. New York:Academic Press, 1982: 1491-503.
9. Kamiyama T. Toxoplasma-induced activities of peritoneal and spleen natural killer cells from beige mice against thymocytes and YAC-1 lymphoma targets. Infect Immun 1984;43:975-80.
10. Hauscer WE Jr, Tsai V. Acute toxoplasma infection of mice induces spleen NK cells that are cytotoxic for Toxoplasma gondii in vitro. J Immunol 1986;136:313-19.
11. Kirkpatrick CE, Farrell JP, Warner JF, Dennert T. Participation of natural killer cells in the recovery of mice from visceral leishmaniasis. Cell Immunol 1985;92:163-71.
12. Kirkpatrick EC, Farrell JP. Splenic natural killer-cell activity in mice infected with Leishmania donovani. Cell Immunol 1984;85: 201-14.
13. Albright JW, Munger WE, Henkart PA, Albright JF. The toxicity of rat large granular lymphocyte tumor cells and their cytoplasmic granules for rodent and African trypanosomes. J Immunol 1988;140:2774-8.
14. Hatcher FM, Kuhn RE. Destruction of Trypanosoma cruzi by natural killer cells. Science 1982;218:295-6.
15. Zunino SJ, Hudig D. Interactions between human natural killer (NK) lymphocytes and yeast cells: human NK cells do not kill Candida albicans, although C. albicans blocks NK lysis of K562 cells. Inf Immun 1988;56:564-9.
16. Petkus AF, Baum LL. Natural killer cell inhibition of young spherules and endospores of Coccicioides immitis. J Immunol 1987;139:3107-11.
17. Hidore MR, Murphy JW. Natural cellular resistance of beige mice against Cryptococcus neoformans. J Immunol 1986;137: 3624-31.
18. Jimenez BE, Murphy JW. In vivo effects of natural killer cells against Paracoccidioides brasiliensis yeast phase. Inf Immun 1984;46:552-8.
19. Marconi P, Scaringi L, Tissi L et al. Induction of natural killer cell activity by inactivated Candida albicans in mice. Inf Immun 1985;50:297-303.
20. Murphy JW, McDaniel DO. In vitro reactivity of natural killer (NK) cells against Cryptococcus neoformans. J Immunol 1982; 128:1577-83.
21. Nabavi N, Murphy JW. In vitro binding of natural killer cells to Cryptococcus neoformans targets. Inf Immun 1985;50:50-7.
22. Subauste CS, Dawson L, Remington JS. Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondii. J Exp Med 1992;76:1511-19.
23. Sher A, Oswald IP, Hieny S, Gazzinelli RT. Toxoplasma gondii induces a T-independent IFN-gamma response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-alpha. J Immunol 1993;150:3982-9.
24. Goyal M, Ganguly NK, Mahajan RC. Natural killer cell cytotoxicity against Toxoplasma gondii in acute and chronic murine toxoplasmosis. Med Sci Res 1988;6:375-7.
25. Evans DL, Gratzek JB. Immune defense mechanisms in fish to protozoan and helminth infections. Amer Zoologist 1989;29: 409-18.
26. Leary JH III, Evans DL, Jaso-Friedmann L. Partial amino acid sequence of a novel protozoan parasite antigen that inhibits nonspecific cytotoxic cell activity. Scand J Immunol 1994;40: 158-64.
27. Jaso-Friedmann L, Leary JH III, Warren J, McGraw RA, Evans DL. The antigen recognized by nonspecific cytotoxic cells is a conserved protein expressed on protozoan parasites and mammalian tumor cells. J Mol Immunol 1996;.
28. Jaso-Friedmann L, Evans DL, Grant CC, St. John A, Harris DT, Koren HS. Characterization by monoclonal antibodies of a target cell antigen complex recognized by nonspecific cytotoxic cells. J Immunol 1988;141:2861-8.
29. Jaso-Friedmann L, Harris DT, St. John A, Koren HS, Evans DL. A monoclonal antibody-purified soluble target cell antigen inhibits nonspecific cytotoxic cell activity. J Immunol 1990;144:2413-18.
30. Harris DT, Jaso-Friedmann L, Devlin RB, Koren HS, Evans DL. Identification of a human natural killer cell target cell antigen with monoclonal antibodies. J Immunol 1989;143:727-35.
31. Reynolds SR, Shoemaker CB, Harn DA. T and B cell epitope mapping of SM23, an integral membrane protein of Schistosoma mansoni. J Immunol 1992;149:3995-4001.
32. Reynolds SR, Dahl CE, Harn DA. T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase. J Immunol 1994;152:193-200.
33. Denkers EY, Gazzinelli RT, Hieny S, Caspar P, Sher A. Bone marrow macrophages process exogenous Toxoplasma gondii polypeptides for recognition by parasite-specific cytolytic T lymphocytes. J Immunol 1993;150:517-26.
34. Harn DA, Gu W, Oligino LD, Mitsuyama M, Gebremichael A, Richter D. A protective monoclonal antibody specifically recognizes and alters the catalytic activity of Schistosome triosephosphate isomerase. J Immunol 1992;148:562-7.
35. Haregewoin A, Edwin C, Horn RC, Finberg R. A 21-mer synthetic peptide of toxic shock syndrome toxin 1, TSST-1[5878]. activates T cells by binding to MHC class II and by an MHC unrestricted xenostimulatory pathway. Immunol Invest 1994;23:413-20.
36. Rammensee H-G, Falk K, Rotzschke O. Peptides naturally presented by MHC class I molecules. Ann Rev Immunol 1993;11:213-15.
37. Jaso-Friedmann L, Leary JH III, Weisman Z, Evans DL. Activation of nonspecific cytotoxic cells with a multiple antigenic peptide: specificity and requirements for receptor crosslinkage. Cell Immunol 1996; in press.
38. Oka T, Kikumoto Y, Itakura K, Morton DL, Irie RF. A human monoclonal antibody identified an immunoreactive tetrapeptide sequence (Lys-Try-Gln-Ile) in 43-kD protein of human melanoma. Cancer Res 1994;54:3511-15.
39. Engelhard VH. Structure of peptides associated with MHC class I molecules. Curr Biol 1994;6:13-20.
40. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991;351:290-6.